A Phase 1, Open-label, Multiple-Ascending Dose Study of the Safety and Tolerability of T3011 in Advanced Cutaneous or Subcutaneous Malignancies

  • Haydon, Andrew (Primary Chief Investigator (PCI))
  • Hawkins, Cheryl-Ann (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date20/01/20 → 31/12/25

Keywords

  • Medical Oncology
  • Cutaneous Malignancies
  • Clinical trial